ALOXE3 and esophageal squamous cell carcinoma: Among these, SLC27A5 and ALOXE3 were not only highly expressed in pCR patients (P < 0.01 and P = 0.01, Figure 2C), but also significantly correlated with a favorable prognosis of ESCC (P < 0.001, Figures 2E, F).